Back to search results

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

Abroad (travel likely)Recruiting

Conditions

Thyroid Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Lombardi Comprehensive Cancer Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Lourdes M Inbar-Albo, MD,MSc. Project Director) · thyroidcancerstudy@georgetown.edu · 202-687-3628
    Contact: Study coordinator (Jacqueline Jonklaas, MD) · jonklaaj@georgetown.edu · 202-687-3628
    Contact: Principal Investigator (Jacqueline Jonklaas, MD, PhD, MPH)
    Contact: Principal Investigator (Kristi D Graves, Ph.D.)

  • MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Leila Shobab, MD) · Leila.Shobab@medstar.net · 202-877-0526
    Leila Shobab, MD, Assistant Professor (Sub-investigator)

  • Inova Health System, Falls Church, Virginia, United States

    Contact: Study coordinator (Samantha Diamond, MD) · Samantha.Diamond-rossi@inova.org · ‭703-776-3574‬
    Samantha Diamond-Rossi, MD (Sub-investigator)
View source on ClinicalTrials.gov(opens in a new tab)